| dc.contributor.author | Epole Ntungwe | |
| dc.contributor.author | Eva María Domínguez-Martín | |
| dc.contributor.author | Catarina Teodósio | |
| dc.contributor.author | Silvia Teixidó-Trujillo | |
| dc.contributor.author | Natalia Armas Capote | |
| dc.contributor.author | Lucilia Saraiva | |
| dc.contributor.author | Ana María Díaz-Lanza | |
| dc.contributor.author | Noélia Duarte | |
| dc.contributor.author | Patrícia Rijo | |
| dc.contributor.other | CBIOS—Universidade Lusófona Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisboa, Portugal | |
| dc.contributor.other | CBIOS—Universidade Lusófona Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisboa, Portugal | |
| dc.contributor.other | CBIOS—Universidade Lusófona Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisboa, Portugal | |
| dc.contributor.other | Centro Atlántico del Medicamento S.A., Avenida Trinidad 61, 7ª Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain | |
| dc.contributor.other | Centro Atlántico del Medicamento S.A., Avenida Trinidad 61, 7ª Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain | |
| dc.contributor.other | LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira n.º 228, 4050-313 Porto, Portugal | |
| dc.contributor.other | Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100—Campus Universitario, 28805 Alcalá de Henares, Spain | |
| dc.contributor.other | Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal | |
| dc.contributor.other | CBIOS—Universidade Lusófona Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisboa, Portugal | |
| dc.date.accessioned | 2021-04-24T00:04:36Z | |
| dc.date.available | 2025-10-02T04:18:08Z | |
| dc.date.issued | 01-04-2021 | |
| dc.identifier.issn | - | |
| dc.identifier.uri | https://www.mdpi.com/1424-8247/14/5/402 | |
| dc.description.abstract | <i>Plectranthus</i> species (Lamiaceae) have been employed in traditional medicine and this is now validated by the presence of bioactive abietane-type diterpenoids. Herein, sixteen <i>Plectranthus</i> acetonic extracts were prepared by ultrasound-assisted extraction and their biological activity was screened. The antimicrobial activity of each extract was screened against yeasts, and Gram-positive and Gram-negative bacteria. The <i>P. hadiensis</i> and <i>P. mutabilis</i> extracts possessed significant activity against <i>Staphylococcus aureus</i> and <i>Candida albicans</i> (microdilution method). Moreover, all extracts showed antioxidant activity using the DPPH method, with <i>P. hadiensis</i> and <i>P. mutabilis</i> extracts having the highest scavenging activities. Selected by the <i>Artemia salina</i> model, <i>P. hadiensis</i> and <i>P.ciliatus</i> possessed low micromolar anti-proliferative activities in human colon, breast, and lung cancer cell lines. Furthermore, the most bioactive extract of <i>P. hadiensis</i> leaves and the known abietane diterpene, 7α-acetoxy-6β-hydroxyroyleanone isolated from this plant, were tested against the aggressive type triple negative breast cancer (MDA-MB-231S). <i>P. hadiensis</i> extract reduced the viability of MDA-MB-231S cancer cell line cells, showing an IC<sub>50</sub> value of 25.6 µg/mL. The IC<sub>50</sub> value of 7α-acetoxy-6β-hydroxyroyleanone was 5.5 µM (2.15 µg/mL), suggesting that this lead molecule is a potential starting tool for the development of anti-cancer drugs. | |
| dc.format | - | |
| dc.language.iso | EN | |
| dc.publisher | MDPI AG | |
| dc.relation.uri | ['https://www.journals.elsevier.com/applied-computing-and-geosciences', 'https://www.elsevier.com/journals/applied-computing-and-geosciences/2590-1974/guide-for-authors', 'https://www.elsevier.com/authors/open-access/choice#waivers'] | |
| dc.rights | ['CC BY', 'CC BY-NC-ND', 'CC BY-NC'] | |
| dc.subject | ['applied computing', 'geophysics', 'informatics', 'geosciences', 'Geography. Anthropology. Recreation', 'G', 'Geology', 'QE1-996.5', 'Electronic computers. Computer science', 'QA75.5-76.95'] | |
| dc.subject.lcc | Medicine | |
| dc.title | Preliminary Biological Activity Screening of <i>Plectranthus</i> spp. Extracts for the Search of Anticancer Lead Molecules | |
| dc.type | Article | |
| dc.description.keywords | <i>Plectranthus</i> | |
| dc.description.keywords | royleanone | |
| dc.description.keywords | 7α-acetoxy-6β-hydroxyroyleanone | |
| dc.description.keywords | <i>ent</i>-abietane | |
| dc.description.keywords | antitumoral activity | |
| dc.description.keywords | antimicrobial activity | |
| dc.description.pages | - | |
| dc.description.doi | 10.3390/ph14050402 | |
| dc.title.journal | Pharmaceuticals | |
| dc.identifier.e-issn | 1424-8247 | |
| dc.identifier.oai | oai:doaj.org/journal:63b3cd57c15e4da5a5b2b575907e841e | |
| dc.journal.info | Volume 14, Issue 5 | |